Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: A prospective, randomized trial
- 984 Downloads
To determine the efficacy and tolerability of an enteric-coated peppermint-oil formulation (Colpermin), we conducted a prospective, randomized, double-blind, placebo-controlled clinical study in 110 outpatients (66 men/44 women; 18–70 years of age) with symptoms of irritable bowel syndrome. Patients took one capsule (Colpermin or placebo) three to four times daily, 15–30 min before meals, for 1 month. Fifty-two patients on Colpermin and 49 on placebo completed the study. Forty-one patients on Colpermin (79%) experienced an alleviation of the severity of abdominal pain (29 were pain-free); 43 (83%) had less abdominal distension, 43 (83%) had reduced stool frequency, 38 (73%) had fewer borborygmi, and 41 (79%) less flatulence. Corresponding figures for the placebo group were: 21 patients (43%) with reduced pain (4 were pain-free) 14 (29%) with reduced distension, 16 (32%) with reduced stool frequency, 15 (31%) with fewer borborygmi, and 11 (22%) with less flatulence. Symptom improvements after Colpermin were significantly better than after placebo (P<0.05; Mann-Whitney U-test). One patient on Colpermin experienced heartburn (because of chewing the capsules) and one developed a mild transient skin rash. There were no significant changes in liver function test results. Thus, in this trial, Colpermin was effective and well tolerated.
Key wordsColpermin irritable bowel syndrome peppermint oil
- 3.Drossmann DA. Irritable bowel syndrome. Gastroenterologist 1994;2:315–326.Google Scholar
- 5.Fukuda S, Muranaka M, Nomura T, Satake M. Brain-gut interactions in irritable bowel syndrome: Physiological and psychological aspects. Nippon Rinsho Jpn J Clin Med 1992;50:2703–2711.Google Scholar
- 10.Schneider MME, Otten MH. Efficacy of Colpermin in the treatment of patients with irritable bowel syndrome (abstract). Gastroenterology 1990;98(5):A389.Google Scholar